financetom
Business
financetom
/
Business
/
Dollar General's Improvements 'Sustainable' Despite Market Reaction to Fiscal Q4, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dollar General's Improvements 'Sustainable' Despite Market Reaction to Fiscal Q4, UBS Says
Mar 16, 2026 9:31 AM

12:05 PM EDT, 03/16/2026 (MT Newswires) -- Dollar General's ( DG ) improvements are sustainable despite the market's overreaction to its fiscal Q4 results, UBS said in a note Friday.

The analysts said the company's execution is getting stronger, driving traffic growth and balanced comparable sales, particularly in higher-margin discretionary categories. This strength comes from its value offerings and brand partnerships rather than tariff-driven pricing.

The analysts said they see the recent stock pullback as a good entry point. They added that market concerns about a February slowdown appear overstated, as business has bounced back once weather-related disruptions eased. Other perceived challenges, such as SNAP benefit cuts, are manageable and have already been factored into guidance.

The analysts also said recent gas price increases are unlikely to impact consumer behavior unless prices exceed $4 per gallon, and any potential shift may even benefit Dollar General ( DG ) through trade-down effects and increased local shopping.

"Overall, we think Dollar General ( DG ) appears to be progressing steadily as it works through execution improvements and benefits from new initiatives. In our view, the company still has a significant runway ahead to capture the benefits of these efforts on its profit and loss. As such, we remain quite bullish on the stock," the analysts said.

UBS has a buy rating and a price target of $168 on Dollar General ( DG ).

Price: 134.22, Change: +2.38, Percent Change: +1.80

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Coinbase Third-Quarter Revenue Misses Estimates; Shares Fall: Analysts
Coinbase Third-Quarter Revenue Misses Estimates; Shares Fall: Analysts
Oct 31, 2024
Coinbase third-quarter net revenue missed estimates.Institutional interest in the stock is growing as it becomes a more important component of various equity indices, JMP said.The U.S. presidential election is an important short-term catalyst for both Coinbase and the industry, and may lead to a more benign regulatory backdrop, the analysts said.Coinbase (COIN) shares fell after the crypto exchange reported a...
Robinhood Swings to Q3 Profit, Revenue Increases
Robinhood Swings to Q3 Profit, Revenue Increases
Oct 31, 2024
04:54 PM EDT, 10/30/2024 (MT Newswires) -- Robinhood Markets ( HOOD ) reported Q3 earnings Wednesday of $0.17 per diluted share, compared with a loss of $0.09 per share a year earlier. Analysts polled by Capital IQ expected $0.18. Revenue for the quarter ended Sept. 30 was $637 million, up from $467 million a year earlier. Analysts surveyed by Capital...
Tamarack Valley Energy Q3 Earnings Up, but Misses Forecast; Corporate Guidance and Dividend Increase
Tamarack Valley Energy Q3 Earnings Up, but Misses Forecast; Corporate Guidance and Dividend Increase
Oct 31, 2024
06:32 AM EDT, 10/31/2024 (MT Newswires) -- Tamarack Valley Energy ( TNEYF ) on Thursday reported an increase in third quarter earnings, even if it missed forecasts, as strong production in the quarter prompted it to increase its dividend. Third-quarter earning per share basic and diluted rose to $0.17 compared with $0.02 a year earlier. The consensus forecast at Capital...
Merck third quarter better than expected, but Gardasil sales sag in China again
Merck third quarter better than expected, but Gardasil sales sag in China again
Oct 31, 2024
Oct 31 (Reuters) - Merck & Co ( MRK ) posted higher-than-expected third-quarter earnings on Thursday on strong sales of its blockbuster cancer treatment Keytruda, but the U.S. drugmaker also flagged a second straight quarter of weak demand for its Gardasil vaccine in China. Gardasil, which prevents cancers caused by the human papillomavirus, has been one of Merck's ( MRK...
Copyright 2023-2026 - www.financetom.com All Rights Reserved